Dr. Reddy’s facility in Andhra Pradesh gets 2 U.S. FDA observations

The company will address the observations within the stipulated timeline.
More news in Industry
IRDAI imposes ₹2 cr penalty on Star HealthJewellery demand remains resilient for Q3 despite gold price surge